Meal Replacement + Financial Incentives Beneficial for Teens With Obesity

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, June 17, 2024 -- For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater reduction in body mass index (BMI) and total body fat mass than MRT alone, according to a study published online June 17 in JAMA Pediatrics.

Amy C. Gross, Ph.D., from the University of Minnesota Center for Pediatric Obesity Medicine in Minneapolis, and colleagues examined the effect of MRT plus FIs versus MRT alone on BMI, body fat, and cardiometabolic risk factors in adolescents with severe obesity in a randomized clinical trial conducted from 2018 to 2022. A total of 126 adolescents with severe obesity were included in the study: Half received MRT plus FIs and half received MRT alone.

The researchers found that the mean BMI reduction was −5.9 percentage points greater at 52 weeks in the MRT plus FIs group versus MRT-alone group. A greater reduction in mean total body fat mass by −4.8 kg was seen for the MRT plus FIs group, and it was cost-effective compared with MRT alone (incremental cost-effectiveness ratio, $39,178 per quality-adjusted life year). No significant between-group differences were seen in cardiometabolic risk factors or unhealthy weight control behaviors.

"It is possible that incentives allowed participants to better adhere to the meal plan over the course of the year, resulting in meaningful BMI and body fat reduction," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-18 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords